Halozyme Therapeutics | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amarin USD 650.22M 51.62M 2024-09
Amgen USD 29.03B 2.26B 2024-12
Baxter International USD 8.85B 11M 2024-12
Cytokinetics USD 1.11B 89.34M 2024-12
DBV Technologies USD 68.76M 21.2M 2024-09
Eli Lilly USD 32.74B 1.32B 2024-12
Halozyme Therapeutics USD 1.09B 41.64M 2024-12
Indivior 799M 65M 2024-09
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
MannKind USD 268.31M 59.36M 2024-12
Pfizer USD 50.36B 7.14B 2024-12
United Therapeutics USD 3.87B 126.5M 2024-12



Halozyme Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.